Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Intrinsic activating properties of GP IIb/IIIa blockers.

K Peter¹, M Schwarz, T Nordt

¹Department of Cardiology and Angiology, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.

Thrombosis Research

|September 25, 2001

Summary

Glycoprotein IIb/IIIa (GP IIb/IIIa) blockers, used in treating blood clots, may paradoxically activate platelets. Aspirin can inhibit this activation, a key finding for clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Usability and feasibility of E-nergEYEze: a blended vision-specific E-health based cognitive behavioral therapy and self-management intervention to reduce fatigue in adults with visual impairment.

BMC health services research·2023

Same author

Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.

West African journal of medicine·2023

Same author

The effectiveness of motivational interviewing on adherence to wearing orthopedic shoes in people with diabetes at low-to-high risk of foot ulceration: A multicenter cluster-randomized controlled trial.

Diabetes research and clinical practice·2023

Same author

Attitudes and experiences towards the application of motivational interviewing by podiatrists working with people with diabetes at high-risk of developing foot ulcers: a mixed-methods study.

Journal of foot and ankle research·2022

Same author

Using motivational interviewing combined with digital shoe-fitting to improve adherence to wearing orthopedic shoes in people with diabetes at risk of foot ulceration: study protocol for a cluster-randomized controlled trial.

Trials·2021

Same author

Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.

Purinergic signalling·2021

Area of Science:

Pharmacology
Hematology
Biochemistry

Background:

Glycoprotein IIb/IIIa (GP IIb/IIIa) blockers are critical in managing thrombotic events.
Controversy exists regarding their potential intrinsic activating properties.
Previous clinical trials with oral GP IIb/IIIa blockers yielded suboptimal outcomes.

Purpose of the Study:

To investigate the intrinsic activating properties of GP IIb/IIIa blockers.
To explore the mechanism of platelet activation induced by these blockers.
To assess the clinical relevance of aspirin's inhibitory effect on this activation.

Main Methods:

Analysis of experimental data on ligand mimetic GP IIb/IIIa blockers.
Evaluation of fibrinogen binding to alpha(IIb)beta(3) receptors.

Related Experiment Videos

Assessment of platelet aggregation in response to GP IIb/IIIa blockers and aspirin.

Main Results:

Ligand mimetic GP IIb/IIIa blockers demonstrate intrinsic activating effects.
This activation leads to fibrinogen binding and platelet aggregation.
Aspirin effectively inhibits GP IIb/IIIa blocker-induced platelet aggregation.

Conclusions:

GP IIb/IIIa blockers may possess intrinsic platelet-activating properties.
Aspirin co-administration is a clinically significant finding for mitigating this effect.
Thrombocytopenia associated with GP IIb/IIIa blockers might be linked to platelet activation.